Privi Speciality Chemicals Delivers Strong Q2 FY27 With Robust Margin Expansion
Privi Speciality Chemicals Ltd · Investor Presentation · 30 Oct 2026, 3:09 pm
Privi Speciality Chemicals Delivers Strong Q2 FY27 With Robust Margin Expansion Privi Speciality Chemicals reported a strong Q2 FY27 performance, with total income rising 13.9% YoY to Rs 773.16 Cr and EBITDA increasing 16.7% YoY to Rs 212.49 Cr, expanding margins by 65 bps to 27.5%. Net profit attributable to the company grew 24.6% YoY to Rs 117.03 Cr. Balance sheet deleveraging progressed well, with net debt to EBITDA improving 32.1% YoY to 1.07x. Under its "5k:1k" roadmap, the company targets Rs 5,000 Cr in revenue and Rs 1,000+ Cr EBITDA by FY29–30.
Original exchange filing (PDF)
More announcements from Privi Speciality Chemicals Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund · 18 Nov 2026
- Announcement under Reg 30 - Transcript of Q2 Earnings Call held on October 30, 2026. · 03 Nov 2026
- Outcome of Earnings Call held on 30.10.2026 @ 04:00 pm - Audio Link · 31 Oct 2026
- Outcome of Board Meeting held on October 29.10.2026 to consider and approve Financial Results of Q2 FY27, declaration of Interim Dividned and Proposed investment in Solar Power Project. · 29 Oct 2026
- Outcome of Board Meeti ng - Approving Record Date for the purpose of Interim Dividend · 29 Oct 2026
- Outcome of Board Meeting - Approval of 1st Interim Dividned FY 2026-27 · 29 Oct 2026
- Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026 · 29 Oct 2026
- Privi Speciality Chemicals Limited has submitted to the Exchange, the outcome of the Board Meeting held on October 29,2026. · 29 Oct 2026
